BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32243733)

  • 1. Effect of high ligation on survival of patients undergoing surgery for primary colorectal cancer and synchronous liver metastases.
    Matsui S; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Ishida T; Yamada T; Kondo T; Yamauchi S; Sugihara K; Kitagawa Y
    BJS Open; 2020 Jun; 4(3):508-515. PubMed ID: 32243733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
    Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
    Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Okuno M; Goumard C; Mizuno T; Kopetz S; Omichi K; Tzeng CD; Chun YS; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2018 Aug; 105(9):1200-1209. PubMed ID: 29664996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.
    Väyrynen V; Wirta EV; Seppälä T; Sihvo E; Mecklin JP; Vasala K; Kellokumpu I
    BJS Open; 2020 Aug; 4(4):685-692. PubMed ID: 32543788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer.
    Scherman P; Syk I; Holmberg E; Naredi P; Rizell M
    BJS Open; 2020 Feb; 4(1):118-132. PubMed ID: 32011815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors of colorectal cancer patients with synchronous liver metastasis treated with simultaneous liver and colorectal resection].
    Wang Z; Zhou ZX; Liang JW; Bai XF; Bi JJ
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):372-5. PubMed ID: 18953839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.
    Björnsson B; Sparrelid E; Røsok B; Pomianowska E; Hasselgren K; Gasslander T; Bjørnbeth BA; Isaksson B; Sandström P
    Eur J Surg Oncol; 2016 Apr; 42(4):531-7. PubMed ID: 26830731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
    Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
    Sadot E; Groot Koerkamp B; Leal JN; Shia J; Gonen M; Allen PJ; DeMatteo RP; Kingham TP; Kemeny N; Blumgart LH; Jarnagin WR; DʼAngelica MI
    Ann Surg; 2015 Sep; 262(3):476-85; discussion 483-5. PubMed ID: 26258316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.
    Hallet J; Sa Cunha A; Adam R; Goéré D; Bachellier P; Azoulay D; Ayav A; Grégoire E; Navarro F; Pessaux P;
    Br J Surg; 2016 Sep; 103(10):1366-76. PubMed ID: 27306949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival following delayed presentation and resection of colorectal liver metastases.
    Swan PJ; Welsh FK; Chandrakumaran K; Rees M
    Br J Surg; 2011 Sep; 98(9):1309-17. PubMed ID: 21598236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hepatectomy and hepatic pedicle lymphadenectomy in colorectal liver metastases is justified.
    Hodgson R; Sethi H; Ling AH; Lodge P
    HPB (Oxford); 2017 Jun; 19(6):525-529. PubMed ID: 28215513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S
    Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.